VCU Medical Center, Richmond, VA, USA.
Enferm Infecc Microbiol Clin. 2011 Mar;29 Suppl 2:3-9. doi: 10.1016/S0213-005X(11)70002-7.
The echinocandins anidulafungin, caspofungin, and micafungin have a broad and similar spectrum of in vitro and in vivo activity against most Candida spp. Minimal inhibitory concentrations (MICs) for Candida spp. are usually below 1 μg/mL for most isolates. The exceptions are Candidaparapsilosis and C. guilliermondii. Species-specific clinical breakpoints (CBPs) and epidemiologic cutoff values (ECVs) have been proposed by the Clinical and Laboratory Standards Institute (CLSI) for the eight most common Candida spp. versus each echinocandin; these values are useful to detect in vitro antifungal resistance (CBPs) and to identify isolates harboring fks mutations or having reduced susceptibility (ECVs). This paper presents a review of the literature (2006-2010) regarding the in vitro activity similarities or differences among the three echinocandins against Candida spp.; different parameters or measurements of in vitro potency were evaluated. The focus of the review is the non-Candida albicans species.
棘白菌素类中的阿尼芬净、卡泊芬净和米卡芬净在体外和体内对大多数念珠菌属都具有广谱而相似的活性。大多数分离株对念珠菌属的最小抑菌浓度 (MIC) 通常低于 1μg/mL。但近平滑念珠菌和季也蒙念珠菌除外。临床和实验室标准化研究所 (CLSI) 针对 8 种最常见的念珠菌属与每种棘白菌素,提出了针对每种棘白菌素的种特异性临床折点 (CBPs) 和流行病学 cutoff 值 (ECVs);这些值有助于检测体外抗真菌耐药性 (CBPs),并识别携带 fks 突变或敏感性降低的分离株 (ECVs)。本文回顾了 2006-2010 年棘白菌素类药物对念珠菌属体外活性相似性或差异性的文献;评估了不同的体外效力参数或测量方法。综述的重点是非白念珠菌属物种。